GENERATE study: Remote genetic education boosts testing rates for inherited cancer risk

Even as it’s become clear that an inherited susceptibility to some cancers is more common than once thought, genetic testing of family members of cancer patients hasn’t increased as much as experts had hoped.

Amid backlash, Novo Nordisk reports positive cardiovascular profile for Wegovy – Pharmaceutical Technology

Considering the positive data, Novo Nordisk is planning to file for Wegovy’s label expansion in both the US and the European Union (EU) in 2023.

August 8, 2023

Opinion | PBMs Are Stacking the Deck Against Patients and Independent Physician Practices

I often hear my patients ask the same questions: Why do I need to change to another infusible biosimilar again? Why do I need to

August 12, 2024

FDA loosens side effect reporting requirements for some CAR-T therapies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.